Enovis Corp (ENOV)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $1.60B
Last updated: Nov 17, 2026 at 4:20 PM ET
Enovis Corp (ENOV) Stock Chart
Enovis (ENOV) has a latest price of $27.20 on Nov 17, 2026, 14.1% below its 52-week high of $31.67. Its price fell 9.3% over the past 12 months. The month-end price fell 63.6% over the 10 years through Oct 2026, a compound annual decline of 9.6%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $88.85 in Oct 2021 and its lowest $18.27 in Sep 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ENOV with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ENOV.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 2.6%, and over 6 months it rose 5.6%. The month-end price fell 56.6% over the 3 years through Oct 2026, a compound annual decline of 24.3%.
| Period | Change |
|---|---|
| 1 month | +36.9% |
| 3 months | +2.6% |
| 6 months | +5.6% |
| 12 months | -9.3% |
| 12 months, with dividends | -9.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -56.6% | -24.3% |
| 5 years | -77.6% | -25.9% |
| 10 years | -63.6% | -9.6% |
Price by Year
Its best calendar year was 2019, when the price rose 74.1%, and its weakest was 2018, when it fell 47.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $19.91 | -25.3% |
| 2025 | $26.64 | -39.3% |
| 2024 | $43.88 | -21.7% |
| 2023 | $56.02 | +4.7% |
| 2022 | $53.52 | -32.4% |
| 2021 | $79.12 | +20.2% |
| 2020 | $65.82 | +5.1% |
| 2019 | $62.62 | +74.1% |
| 2018 | $35.97 | -47.2% |
| 2017 | $68.19 | +10.3% |
Trading Range
The price is 30.4% above its 50-day average of $20.85 and 16.8% above its 200-day average of $23.29.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $27.20 | |
| 52-week high | $31.67 | -14.1% |
| 52-week low | $16.70 | +62.9% |
| 50-day average | $20.85 | +30.4% |
| 200-day average | $23.29 | +16.8% |
Price Risk
Over 3 years, its largest fall from a peak was 72.7%.
| Measure | Value |
|---|---|
| 1-year beta | 0.94 |
| Largest fall, 1 year | -44.5% |
| Largest fall, 3 years | -72.7% |
Valuation
Enovis traded at 8.1x earnings at the end of 2025, against a 5-year median of 13.7x and a 10-year median of 12.6x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ENOV
What is ENOV's 1-year price change?
Enovis's price fell 9.3% over the past 12 months. With dividends included, the 12-month total return was -9.3%.
What is ENOV's 5-year price change?
Enovis's month-end price fell 77.6% over the 5 years through Oct 2026, a compound annual decline of 25.9%. These figures leave out dividends.
What is ENOV's 52-week high and low?
Enovis's 52-week high is $31.67 and its 52-week low is $16.70. Its latest price of $27.20 on Nov 17, 2026 is 14.1% below the high.
What is ENOV's beta?
Enovis's 1-year beta against the S&P 500 is 0.94, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 44.5%.
Is the ENOV chart free?
Yes. Advanced Charting for ENOV is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ENOV pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors